URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS.

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Abstract Text:

Y NAKAGAWA,M R SHETLAR,S H WENDER,

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Publishing Authors By Initials

Y NAKAGAWA,MR SHETLAR,SH WENDER,

For similar fluids and secretions: body fluids: urine research abstracts see: fluids and secretions: body fluids: urine research

PUBMED ID PMID:

MEDLINE DATE:

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biochimica et biophysica acta

VOLUME: 97

Page Numbers: 233-41

Journal Abbreviation: Biochim. Biophys. Acta

ISSN: 0006-3002

DAY: 15

MONTH: Feb

YEAR: 1965

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 217513

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Keywords Mesh Terms:

KEYWORDS: Urine

MESH TERMS:

Chemical & Substance for Abstract: URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS. Information

Substance Name: mandelic acid

Registry Number: 90-64-2

Grant and Affiliation Information for URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS.

AFFILIATION:

Country: NETHERLANDS

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biochim Biophys Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS Related Publications

• 3-Hydroxy-2-naphthoic acid as an intermediate in bacterial dissimilation of anthracene.
• A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.
• Colonoscopy surveillance after polypectomy and colorectal cancer resection.
• Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
• Diversity-invasibility across an experimental disturbance gradient in Appalachian Forests.
• EFFECT OF PNEUMOENCEPHALOGRAPHY ON SERUM LIPIDS.
• Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.
• Effects of levodopa on attention deficit disorder, residual type.
• Experimental model for the study of chronic renal ischemia in rats: morphologic, histological and ultra-structural analysis.
• Formation of scopoletin from esculin and esculetin in the rat.
• Genetic study of familial cases of Alzheimer's disease.
• How to increase colorectal cancer screening rates in practice.
• Methylnaphthalene oxidations by pseudomonads.
• Nitrous oxide remains a valuable adjuvant for surgery.
• Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release.
• Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells.
• SPECTRAL IDENTIFICATION STUDIES OF PHENOLIC ACIDS USING ALUMINUM CHLORIDE.
• Spontaneous selective attention in schizophrenia.
• THE EFFECT OF IONIZING RADIATION ON PHYSIOLOGICAL CHANGES IN THE CONTENT OF MINERAL COMPONENTS IN THE BRAIN DURING DEVELOPMENT.
• The influence of encephalography on the system of circulation.
• The microbiology of coal. I. Bacterial oxidation of phenanthrene.
• The use of amberlite resin in a separation of xanthine and guanine.
• Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
• Transition metal-catalyzed intermolecular [5+2] and [5+2+1] cycloadditions of allenes and vinylcyclopropanes.
• Treatment of attention deficit disorder with DL-phenylalanine.
• URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS.
• [Attention deficit hyperactivity disorder in adults : Benchmarking diagnosis using the Wender-Reimherr adult rating scale.]
• [Classification of demyelinizing diseases.]
• [Functional disturbances of the endocrine glands in diseases of the central nervous system.]
• [Hormone therapy in menopause: when not to use.]